DrugRisk Update: Court Rules That Experts Can Testify on NuvaRing Estrogen Bursts in Lawsuit

Share Article

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

News Image
Due to the number of patients filing a NuvaRing lawsuit, approximately 1,097 cases have been consolidated to a special federal court in Missouri.

The birth control safety advocates at DrugRisk.com are alerting women who’ve used the vaginal ring contraceptive NuvaRing of updated legal news on the site. A federal judge overseeing more than 1,000 claims alleging blood clots from the devices recently ruled that experts can present evidence that estrogen bursts from NuvaRing contributed to the clots***.

DrugRisk seeks to improve the safety of patients using prescription drugs and devices by providing the latest warnings, research, legal news and recalls. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.

Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots*.

Due to the number of patients filing a NuvaRing lawsuit, approximately 1,097 cases have been consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. U.S. District Judge Rodney Sippel recently delayed the start of these cases until October 21, 2013, while other cases in a New Jersey court will begin on May 6, 2013**.

Now, DrugRisk has learned that Judge Sippel has ordered that expert witnesses for the patients alleging blood clot injuries can testify that estrogen bursts from the NuvaRing may have contributed to those clots***.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, NuvaRing side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*nejm.org/doi/full/10.1056/NEJMoa1111840
**http://www.judiciary.state.nj.us/mass-tort/nuvaring/cmo24.pdf
***mo.findacase.com/research/wfrmDocViewer.aspx/xq/fac.20130305_0000431.EMO.htm/qx

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website